rs200930438
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_030930.4(UNC93B1):c.1155C>T(p.Gly385Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0021 in 1,545,570 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0078 ( 9 hom., cov: 29)
Exomes 𝑓: 0.0015 ( 10 hom. )
Consequence
UNC93B1
NM_030930.4 synonymous
NM_030930.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.01
Genes affected
UNC93B1 (HGNC:13481): (unc-93 homolog B1, TLR signaling regulator) This gene encodes a protein that is involved in innate and adaptive immune response by regulating toll-like receptor signaling. The encoded protein traffics nucleotide sensing toll-like receptors to the endolysosome from the endoplasmic reticulum. Deficiency of the encoded protein has been associated with herpes simplex encephalitis. [provided by RefSeq, Feb 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 11-67995819-G-A is Benign according to our data. Variant chr11-67995819-G-A is described in ClinVar as [Benign]. Clinvar id is 470487.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.01 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00783 (1191/152040) while in subpopulation AFR AF= 0.0238 (987/41478). AF 95% confidence interval is 0.0226. There are 9 homozygotes in gnomad4. There are 566 alleles in male gnomad4 subpopulation. Median coverage is 29. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UNC93B1 | NM_030930.4 | c.1155C>T | p.Gly385Gly | synonymous_variant | 9/11 | ENST00000227471.7 | NP_112192.2 | |
UNC93B1 | XM_011545290.1 | c.744C>T | p.Gly248Gly | synonymous_variant | 7/9 | XP_011543592.1 | ||
UNC93B1 | XM_011545291.3 | c.600C>T | p.Gly200Gly | synonymous_variant | 6/8 | XP_011543593.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UNC93B1 | ENST00000227471.7 | c.1155C>T | p.Gly385Gly | synonymous_variant | 9/11 | 1 | NM_030930.4 | ENSP00000227471.3 | ||
UNC93B1 | ENST00000525368.1 | n.162C>T | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00782 AC: 1188AN: 151924Hom.: 9 Cov.: 29
GnomAD3 genomes
AF:
AC:
1188
AN:
151924
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00223 AC: 320AN: 143714Hom.: 2 AF XY: 0.00171 AC XY: 133AN XY: 77564
GnomAD3 exomes
AF:
AC:
320
AN:
143714
Hom.:
AF XY:
AC XY:
133
AN XY:
77564
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00148 AC: 2060AN: 1393530Hom.: 10 Cov.: 36 AF XY: 0.00135 AC XY: 930AN XY: 687270
GnomAD4 exome
AF:
AC:
2060
AN:
1393530
Hom.:
Cov.:
36
AF XY:
AC XY:
930
AN XY:
687270
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00783 AC: 1191AN: 152040Hom.: 9 Cov.: 29 AF XY: 0.00762 AC XY: 566AN XY: 74314
GnomAD4 genome
AF:
AC:
1191
AN:
152040
Hom.:
Cov.:
29
AF XY:
AC XY:
566
AN XY:
74314
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Herpes simplex encephalitis, susceptibility to, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at